T1	SectionAnnotate 202 206	HPI:
T2	SectionAnnotate 3606 3620	Social History
T3	SectionSkip 4500 5591	Physical Exam:   Vital Signs - Pulse 51  | Temp 36.1 C (97 F) (Oral)  | Resp 16  | Ht 165.5 cm (5' 5.16") Comment: 10/21/2017 @ ***** | Wt (!) 105.7 kg (233 lb)  | SpO2 97%  | BMI 38.59 kg/m    Constitutional - WDWN, NAD  Eyes - sclera anicteric, PERRL, EOMI  HENT - sinuses nontender, nasal mucosa intact, pharynx without erythema, stomatitis, or thrush   Lymph Nodes - no cervical, supraclavicular, or axillary lymphadenopathy  Respiratory - resonant to percussion throughout, CTA bilaterally; no wheezes, rhonchi, or crackles  Cardiovascular - Normal heart rate, normal rhythm, no murmurs, no edema  Breast - no masses bilaterally  GI - Bowel sounds normal, soft; no tenderness, no distention, no HSM  Musculoskeletal - No tenderness over bones or joints.   Neurologic - Alert & oriented x 3, ambulates w/o difficulty, good strength throughout  Psychiatric - Mood stable; no HI, SI, hallucinations, paranoia, or delusions  Skin - warm without rashes or lesions     Studies:  Available labs, pathology, and imaging were reviewed and independently interpreted, as described above in the HPI
T4	SectionAnnotate 5596 5627	Assessment and Recommendations:
T5	PROBLEM 62 87	early stage breast cancer
T6	TREATMENT 129 146	treatment options
T7	TEST 231 251	screening mammograms
T8	PROBLEM 263 288	a lump in her left breast
T9	TEST 357 370	an evaluation
T10	TREATMENT 424 433	treatment
T11	PROBLEM 480 503	lump in her left breast
T12	TEST 516 536	Diagnostic mammogram
T13	PROBLEM 538 592	irregular spiculated mass in left upper outer quadrant
T14	PROBLEM 610 630	palpable abnormality
T15	PROBLEM 632 688	irregular mass in posterior, inferior, subareolar region
T16	TEST 706 737	Targeted left breast ultrasound
T17	PROBLEM 739 764	irregular hypoechoic mass
T18	TEST 823 855	Targeted right breast ultrasound
T19	PROBLEM 857 882	lobulated hypoechoic mass
T20	TEST 930 936	nipple
T21	TEST 949 951	US
T22	TEST 959 982	left breast core biopsy
T23	TEST 1011 1017	nipple
T24	TEST 1035 1038	IDC
T25	TEST 1044 1046	ER
T26	TEST 1054 1056	PR
T27	TEST 1063 1067	HER2
T28	TEST 1070 1073	IHC
T29	TEST 1078 1088	FISH ratio
T30	TEST 1096 1098	US
T31	TEST 1106 1130	right breast core biopsy
T32	TEST 1160 1166	nipple
T33	TEST 1183 1186	IDC
T34	TEST 1192 1194	ER
T35	TEST 1202 1204	PR
T36	TEST 1211 1215	HER2
T37	TEST 1218 1221	IHC
T38	TEST 1226 1236	FISH ratio
T39	TEST 1246 1255	HER2 copy
T40	TEST 1262 1266	cell
T41	PROBLEM 1273 1304	intermediate nuclear grade DCIS
T42	TEST 1318 1328	Breast MRI
T43	PROBLEM 1330 1375	right - irregular homgeneously enhancing mass
T44	PROBLEM 1414 1437	right breast index mass
T45	PROBLEM 1477 1521	left - irregular homgeneously enhancing mass
T46	PROBLEM 1560 1582	left breast index mass
T47	PROBLEM 1622 1669	multiple prominent low level 1 left axillary LN
T48	PROBLEM 1675 1691	thickened cortex
T49	TEST 1734 1736	US
T50	TREATMENT 1744 1772	left axillary LN core biopsy
T51	PROBLEM 1826 1851	metastatic adenocarcinoma
T52	PROBLEM 1874 1885	tumor cells
T53	PROBLEM 1924 1938	fibrous tissue
T54	PROBLEM 1974 1996	extracapsular invasion
T55	TEST 1998 2002	HER2
T56	TEST 2005 2008	IHC
T57	TEST 2013 2023	FISH ratio
T58	TREATMENT 2041 2071	Left breast partial mastectomy
T59	TREATMENT 2076 2106	axillary lymph node dissection
T60	PROBLEM 2115 2126	grade 3 IDC
T61	TEST 2128 2130	ER
T62	TEST 2137 2139	PR
T63	TEST 2147 2151	HER2
T64	TEST 2158 2168	FISH ratio
T65	TEST 2189 2192	LVI
T66	TEST 2194 2201	margins
T67	PROBLEM 2212 2246	focal high grade DCIS within tumor
T69	TumorCharacteristics 2257 2279	0.7 mm micrometastasis
T70	TumorCharacteristics 2288 2311	extracapsular extension
T71	TEST 2314 2326	MP high risk
T72	TREATMENT 2337 2368	Right breast partial mastectomy
T73	TREATMENT 2373 2403	axillary lymph node dissection
T74	TEST 2429 2431	ER
T75	TEST 2438 2440	PR
T76	BiomarkerName 2447 2451	HER2
T77	TEST 2454 2457	IHC
T78	TEST 2461 2471	FISH ratio
T79	TEST 2482 2484	LN
T80	TREATMENT 2655 2673	her breast surgery
T81	PROBLEM 2684 2708	some mld joint stiffness
T82	TREATMENT 2824 2845	adjuvant chemotherapy
T83	PROBLEM 2963 2972	her tumor
T84	PROBLEM 3006 3014	Oncotype
T85	TREATMENT 3092 3104	chemotherapy
T87	PROBLEM 3211 3219	Diabetes
T88	TEST 3234 3239	HbA1c
T89	PROBLEM 3271 3278	Obesity
T90	TREATMENT 3341 3439	AXILLARY LYMPH NODE DISSECTION Bilateral 10/09/2017    8 LN ON RIGHT; 12 LN ON LEFT    MASTECTOMY
T91	TREATMENT 3441 3497	PARTIAL Bilateral 08/13/2017    WITH BILATERAL REDUCTION
T92	PROBLEM 3561 3574	Breast cancer
T93	PROBLEM 4140 4149	menopause
T94	PROBLEM 4174 4177	HRT
T95	TREATMENT 4377 4388	medications
T96	PROBLEM 4421 4445	Medications    Allergies
T97	TEST 4517 4528	Vital Signs
T98	TEST 4531 4536	Pulse
T99	TEST 4543 4547	Temp
T100	TEST 4553 4554	C
T101	TEST 4572 4576	Resp
T102	TEST 4583 4585	Ht
T103	TEST 4636 4638	Wt
T104	TEST 4664 4668	SpO2
T105	TEST 4676 4679	BMI
T106	PROBLEM 4717 4720	NAD
T107	PROBLEM 4736 4745	anicteric
T108	PROBLEM 4775 4784	nontender
T109	PROBLEM 4823 4831	erythema
T110	PROBLEM 4833 4843	stomatitis
T111	PROBLEM 4848 4868	thrush   Lymph Nodes
T112	PROBLEM 4874 4928	cervical, supraclavicular, or axillary lymphadenopathy
T113	TEST 4956 4966	percussion
T114	TEST 4979 4982	CTA
T115	PROBLEM 4999 5006	wheezes
T116	PROBLEM 5008 5015	rhonchi
T117	PROBLEM 5020 5028	crackles
T118	PROBLEM 5084 5091	murmurs
T119	PROBLEM 5096 5101	edema
T120	PROBLEM 5115 5133	masses bilaterally
T121	PROBLEM 5170 5180	tenderness
T122	PROBLEM 5185 5195	distention
T123	PROBLEM 5200 5203	HSM
T124	PROBLEM 5226 5257	tenderness over bones or joints
T125	PROBLEM 5378 5380	HI
T126	PROBLEM 5382 5384	SI
T127	PROBLEM 5386 5400	hallucinations
T128	PROBLEM 5402 5410	paranoia
T129	PROBLEM 5415 5424	delusions
T130	PROBLEM 5446 5452	rashes
T131	PROBLEM 5456 5463	lesions
T132	TEST 5478 5492	Available labs
T133	TEST 5494 5503	pathology
T134	TEST 5509 5516	imaging
T135	PROBLEM 5687 5710	bilateral breast cancer
T136	TREATMENT 5735 5756	adjuvant chemotherapy
T137	PROBLEM 5790 5838	genomically high risk disease in the left breast
T138	TREATMENT 5917 5926	treatment
T139	PROBLEM 5930 5944	early stage HR
T140	PROBLEM 5946 5950	HER2
T141	PROBLEM 5952 5965	breast cancer
T142	TEST 5980 6001	the available imaging
T143	PROBLEM 6047 6063	2 breast cancers
T144	PROBLEM 6069 6092	very different features
T145	TEST 6136 6138	HR
T146	TEST 6140 6144	HER2
T147	TEST 6178 6190	MP high risk
T148	PROBLEM 6203 6212	a Stage I
T149	TEST 6221 6223	HR
T150	TEST 6225 6229	HER2
T151	PROBLEM 6297 6319	her left breast cancer
T152	PROBLEM 6329 6360	the high clinical risk features
T153	PROBLEM 6372 6382	tumor size
T154	PROBLEM 6384 6401	lymph node status
T155	TREATMENT 6516 6528	chemotherapy
T156	PROBLEM 6584 6593	the tumor
T157	TREATMENT 6611 6621	MammaPrint
T158	TREATMENT 6626 6634	Oncotype
T159	PROBLEM 6647 6662	recurrence risk
T160	TREATMENT 6680 6692	chemotherapy
T161	PROBLEM 6783 6800	high genomic risk
T162	TREATMENT 6818 6830	chemotherapy
T163	TREATMENT 6902 6915	randomization
T164	TreatmentType 6942 6954	chemotherapy
T165	TreatmentType 6987 6999	chemotherapy
T166	PROBLEM 7024 7047	distant recurrence risk
T167	TREATMENT 7091 7112	an absolute reduction
T168	TEST 7116 7119	DFS
T169	PROBLEM 7129 7138	Her tumor
T170	PROBLEM 7172 7186	Oncotype DX RS
T171	TEST 7240 7255	these two tests
T172	PROBLEM 7305 7322	high risk disease
T173	TREATMENT 7361 7373	chemotherapy
T174	PROBLEM 7390 7406	low risk disease
T175	TREATMENT 7527 7534	TAILORx
T176	PROBLEM 7563 7578	her positive LN
T177	PROBLEM 7588 7605	a micrometastasis
T178	TREATMENT 7640 7661	chemotherapy regimens
T179	TREATMENT 7681 7694	TC x 4 cycles
T180	TREATMENT 7700 7704	AC/T
T181	TREATMENT 7843 7858	TC chemotherapy
T182	Symptom 7870 7877	fatigue
T183	Symptom 7879 7895	myelosuppression
T184	PROBLEM 7897 7907	joint pain
T185	PROBLEM 7909 7917	myalgias
T186	PROBLEM 7919 7934	fluid retention
T187	PROBLEM 7936 7955	finger nail changes
T188	PROBLEM 7957 7965	alopecia
T189	PROBLEM 7971 7992	cognitive dysfunction
T190	PROBLEM 8013 8036	her right breast cancer
T191	PROBLEM 8046 8076	the low clinical risk features
T192	PROBLEM 8088 8098	tumor size
T193	TreatmentType 8160 8172	chemotherapy
T194	PROBLEM 8202 8212	this tumor
T195	TEST 8279 8281	HR
T196	PROBLEM 8283 8287	HER2
T197	PROBLEM 8289 8303	breast cancers
T198	TREATMENT 8319 8332	other therapy
T199	TREATMENT 8344 8365	anti-estrogen therapy
T200	TREATMENT 8459 8484	first-line recommendation
T201	TREATMENT 8489 8519	adjuvant anti-estrogen therapy
T202	TEST 8554 8556	HR
T203	PROBLEM 8564 8577	breast cancer
T204	TREATMENT 8581 8603	an aromatase inhibitor
T205	TREATMENT 8641 8661	androgen to estrogen
T206	TREATMENT 8672 8702	the total body estrogen supply
T207	PROBLEM 8716 8740	the typical side-effects
T208	PROBLEM 8752 8763	hot flashes
T209	PROBLEM 8765 8776	arthralgias
T210	PROBLEM 8778 8793	vaginal dryness
T211	PROBLEM 8799 8816	bone density loss
T212	TreatmentType 8913 8925	chemotherapy
T213	TREATMENT 8931 8940	radiation
T214	TREATMENT 8969 8975	a DEXA
T215	TREATMENT 9109 9116	calcium
T216	TREATMENT 9121 9131	vitamin D.
T217	TREATMENT 9307 9333	docetaxel/cyclophosphamide
T218	TREATMENT 9348 9371	radiation  - AI therapy
T219	TREATMENT 9423 9441	a CDK4/6 inhibitor
T220	TREATMENT 9581 9599	the treatment plan
T221	TREATMENT 9616 9632	medication risks
T222	TREATMENT 9634 9656	lifestyle modification
T223	PROBLEM 9658 9666	symptoms
T224	TREATMENT 9671 9690	therapeutic options
T225	Radiology 241 251	mammograms
A1	NegationModalityVal T225 negated
A2	IntentVal T225 screening
T226	Symptom 265 269	lump
A3	IsPresentOnFirstCancerDiagnosis T226 yes
A4	IsCausedByDiagnosedCancer T226 yes
A5	ChronicVal T226 non-chronic
A6	ContinuityVal T226 new
T227	Site 282 288	breast
T228	Laterality 277 281	left
R1	LateralityOfSite Arg1:T228 Arg2:T227	
R2	SiteOf Arg1:T227 Arg2:T226	
T229	Datetime 292 305	February 2017
T230	ProcedureName 360 370	evaluation
A7	IntentVal T230 diagnosis
T231	Datetime 396 405	June 2017
T232	Datetime 461 474	February 2017
T233	Symptom 480 484	lump
A9	IsPresentOnFirstCancerDiagnosis T233 yes
A10	IsCausedByDiagnosedCancer T233 yes
A11	ChronicVal T233 non-chronic
A12	ContinuityVal T233 new
T234	Site 497 503	breast
T235	Laterality 492 496	left
R3	LateralityOfSite Arg1:T235 Arg2:T234	
R4	SiteOf Arg1:T234 Arg2:T233	
T236	Datetime 507 515	06/14/17
T237	Radiology 527 536	mammogram
A13	IntentVal T237 diagnosis
T238	RadPathResult 538 563	irregular spiculated mass
T239	Site 572 592	upper outer quadrant
T240	Laterality 567 571	left
R5	LateralityOfSite Arg1:T240 Arg2:T239	
R6	SiteOf Arg1:T239 Arg2:T238	
R7	ResultOfTest Desc:T238 Test:T237	
T241	Symptom 610 630	palpable abnormality
A15	IsPresentOnFirstCancerDiagnosis T241 yes
A16	IsCausedByDiagnosedCancer T241 yes
A17	ChronicVal T241 non-chronic
A18	ContinuityVal T241 new
T242	RadPathResult 632 646	irregular mass
T243	Site 650 688	posterior, inferior, subareolar region
T244	Laterality 692 697	right
R8	LateralityOfSite Arg1:T244 Arg2:T243	
R9	SiteOf Arg1:T243 Arg2:T242	
R10	ResultOfTest Desc:T242 Test:T237	
T245	Radiology 727 737	ultrasound
A19	IntentVal T245 diagnosis
T246	Site 720 726	breast
T247	Laterality 715 719	left
R11	LateralityOfSite Arg1:T247 Arg2:T246	
R12	SiteOf Arg1:T246 Arg2:T245	
T248	RadPathResult 739 785	irregular hypoechoic mass (1.8 x 2.3 x 2.7 cm)
R13	ResultOfTest Desc:T248 Test:T245	
T249	Site 789 821	1:30 position, 10 cm from nipple
R14	SiteOf Arg1:T249 Arg2:T245	
T250	Radiology 845 855	ultrasound
A21	IntentVal T250 diagnosis
T251	Site 838 844	breast
T252	Laterality 832 837	right
R15	LateralityOfSite Arg1:T252 Arg2:T251	
R16	SiteOf Arg1:T251 Arg2:T250	
T253	RadPathResult 857 901	lobulated hypoechoic mass (1 x 1.1 x 1.2 cm)
R17	ResultOfTest Desc:T253 Test:T250	
T254	Site 905 936	8:00 position, 6 cm from nipple
R18	SiteOf Arg1:T254 Arg2:T253	
T255	Datetime 940 948	06/17/17
T256	ProcedureName 971 982	core biopsy
A23	IntentVal T256 diagnosis
T257	Site 964 970	breast
T258	Laterality 959 963	left
R19	LateralityOfSite Arg1:T258 Arg2:T257	
R20	SiteOf Arg1:T257 Arg2:T256	
T259	Site 986 1017	8:00 position, 6 cm from nipple
R21	SiteOf Arg1:T259 Arg2:T256	
T260	Size 1019 1026	0.75 cm
A24	HistoryVal T260 new
A25	EpisodeDescription T260 FirstOccurrence
T261	Grade 1033 1034	3
A26	HistoryVal T261 new
A27	EpisodeDescription T261 FirstOccurrence
T262	Histology 1035 1038	IDC
A28	HistoryVal T262 new
A29	EpisodeDescription T262 FirstOccurrence
T263	BiomarkerName 1044 1046	ER
A30	HistoryVal T263 new
A31	EpisodeDescription T263 FirstOccurrence
T264	BiomarkerResult 1046 1052	+ 100%
A32	HistoryVal T264 new
A33	EpisodeDescription T264 FirstOccurrence
*	BiomarkerRel T263 T264
T265	BiomarkerName 1054 1056	PR
A34	EpisodeDescription T265 FirstOccurrence
T266	BiomarkerResult 1056 1061	+ 75%
A35	HistoryVal T266 new
A36	EpisodeDescription T266 FirstOccurrence
*	BiomarkerRel T265 T266
T267	BiomarkerName 1063 1067	HER2
A37	HistoryVal T267 new
A38	EpisodeDescription T267 FirstOccurrence
T268	BiomarkerResult 1067 1068	-
A39	HistoryVal T268 new
A40	EpisodeDescription T268 FirstOccurrence
*	BiomarkerRel T268 T267
T269	ProcedureName 1119 1130	core biopsy
A41	IntentVal T269 diagnosis
T270	Site 1112 1118	breast
T271	Laterality 1106 1111	right
R22	LateralityOfSite Arg1:T271 Arg2:T270	
R23	SiteOf Arg1:T270 Arg2:T269	
T272	Site 1134 1166	1:30 position, 10 cm from nipple
R24	SiteOf Arg1:T272 Arg2:T269	
T273	Size 1168 1174	0.6 cm
A42	HistoryVal T273 new
A43	EpisodeDescription T273 FirstOccurrence
R25	TestOrProcedureReveals Test:T269 Desc:T273	
R26	TestOrProcedureReveals Test:T256 Desc:T260	
R27	TestOrProcedureReveals Test:T256 Desc:T261	
T274	Grade 1181 1182	1
A44	HistoryVal T274 new
A45	EpisodeDescription T274 FirstOccurrence
T275	Histology 1183 1186	IDC
A46	HistoryVal T275 new
A47	EpisodeDescription T275 FirstOccurrence
T276	BiomarkerName 1192 1194	ER
A48	HistoryVal T276 new
A49	EpisodeDescription T276 FirstOccurrence
T277	BiomarkerResult 1194 1200	+ 100%
A50	HistoryVal T277 new
A51	EpisodeDescription T277 FirstOccurrence
*	BiomarkerRel T276 T277
R28	TestOrProcedureReveals Test:T269 Desc:T276	
T278	BiomarkerName 1202 1204	PR
A52	HistoryVal T278 new
A53	EpisodeDescription T278 FirstOccurrence
T279	BiomarkerResult 1204 1209	+ 75%
A54	HistoryVal T279 new
A55	EpisodeDescription T279 FirstOccurrence
*	BiomarkerRel T278 T279
R29	TestOrProcedureReveals Test:T269 Desc:T278	
T280	BiomarkerName 1211 1215	HER2
A56	HistoryVal T280 new
A57	EpisodeDescription T280 FirstOccurrence
T282	Histology 1273 1304	intermediate nuclear grade DCIS
A60	HistoryVal T282 new
A61	EpisodeDescription T282 FirstOccurrence
R30	TestOrProcedureReveals Test:T269 Desc:T282	
R31	TestOrProcedureReveals Test:T269 Desc:T280	
T283	Datetime 1309 1317	07/02/17
T284	Radiology 1325 1328	MRI
A62	IntentVal T284 staging
T285	Site 1318 1324	Breast
R32	SiteOf Arg1:T285 Arg2:T284	
T286	Laterality 1330 1335	right
R33	LateralityOfSite Arg1:T286 Arg2:T285	
T287	RadPathResult 1338 1375	irregular homgeneously enhancing mass
A63	RadPathResultVal T287 InitialCancerDiagnosis
T288	Size 1376 1396	(2.3 x 1.4 x 1.1 cm)
A64	HistoryVal T288 new
A65	EpisodeDescription T288 FirstOccurrence
R35	TestOrProcedureReveals Test:T284 Desc:T288	
T289	Site 1438 1475	(at 8:00 position, 13 cm from nipple)
R37	SiteOf Arg1:T289 Arg2:T287	
T290	Laterality 1477 1481	left
T291	RadPathResult 1484 1521	irregular homgeneously enhancing mass
A66	RadPathResultVal T291 InitialCancerDiagnosis
R38	LateralityOfSite Arg1:T290 Arg2:T285	
R39	ResultOfTest Desc:T291 Test:T284	
T292	Size 1522 1542	(2.2 x 3.3 x 2.6 cm)
A67	HistoryVal T292 new
A68	EpisodeDescription T292 FirstOccurrence
R40	TestOrProcedureReveals Test:T284 Desc:T292	
T293	Site 1587 1619	2:00 position, 10 cm from nipple
R41	SiteOf Arg1:T293 Arg2:T291	
T294	LymphNodeInvolvement 1667 1669	LN
A69	HistoryVal T294 new
A70	EpisodeDescription T294 FirstOccurrence
A71	NegationModalityVal T294 affirmed
R42	TestOrProcedureReveals Test:T284 Desc:T294	
T295	Datetime 1725 1733	07/11/17
T296	ProcedureName 1761 1772	core biopsy
A72	IntentVal T296 staging
A73	TreatmentTypeVal T296 others
T297	Site 1749 1760	axillary LN
T298	Laterality 1744 1748	left
R43	LateralityOfSite Arg1:T298 Arg2:T297	
R44	SiteOf Arg1:T297 Arg2:T296	
T299	Site 1773 1807	(3:00 position, 19 cm from nipple)
R45	SiteOf Arg1:T299 Arg2:T296	
T300	Histology 1837 1851	adenocarcinoma
A74	HistoryVal T300 new
A75	EpisodeDescription T300 FirstOccurrence
T301	Metastasis 1826 1836	metastatic
A76	HistoryVal T301 new
A77	EpisodeDescription T301 FirstOccurrence
R46	TestOrProcedureReveals Test:T296 Desc:T301	
R47	TestOrProcedureReveals Test:T296 Desc:T300	
T302	Size 1861 1867	1.5 mm
A78	HistoryVal T302 new
A79	EpisodeDescription T302 FirstOccurrence
R48	TestOrProcedureReveals Test:T296 Desc:T302	
R49	SiteOf Arg1:T299 Arg2:T302	
T303	Histology 1874 1938	tumor cells present in adipose tissue adjacent to fibrous tissue
A80	HistoryVal T303 new
A81	EpisodeDescription T303 FirstOccurrence
R50	TestOrProcedureReveals Test:T296 Desc:T303	
T304	Histology 1974 1996	extracapsular invasion
A82	NegationModalityVal T304 uncertain_in_past
A83	HistoryVal T304 new
A84	EpisodeDescription T304 FirstOccurrence
R51	TestOrProcedureConductedForProblem Test:T296 Prob:T304	
T305	BiomarkerName 1998 2002	HER2
A85	HistoryVal T305 new
A86	EpisodeDescription T305 FirstOccurrence
R52	TestOrProcedureReveals Test:T296 Desc:T305	
T307	Datetime 2032 2040	08/13/17
T308	ProcedureName 2053 2071	partial mastectomy
A90	IntentVal T308 treatment-curative
A91	TreatmentTypeVal T308 local
T309	Site 2046 2052	breast
T310	Laterality 2041 2045	Left
R53	SiteOf Arg1:T309 Arg2:T308	
R54	LateralityOfSite Arg1:T310 Arg2:T309	
T311	ProcedureName 2085 2106	lymph node dissection
A92	IntentVal T311 DiagnosisAndTreatment
A93	TreatmentTypeVal T311 local
T312	Site 2076 2084	axillary
R55	LateralityOfSite Arg1:T310 Arg2:T312	
T313	Grade 2121 2122	3
A94	HistoryVal T313 new
A95	EpisodeDescription T313 FirstOccurrence
T314	Size 2108 2114	6.2 cm
A96	HistoryVal T314 new
A97	EpisodeDescription T314 FirstOccurrence
R56	TestOrProcedureReveals Test:T308 Desc:T314	
T315	Histology 2123 2126	IDC
A98	HistoryVal T315 new
A99	EpisodeDescription T315 FirstOccurrence
T316	BiomarkerName 2128 2130	ER
A100	HistoryVal T316 new
A101	EpisodeDescription T316 FirstOccurrence
T317	BiomarkerResult 2130 2135	+ 99%
A102	NegationModalityVal T317 affirmed
A103	HistoryVal T317 new
A104	EpisodeDescription T317 FirstOccurrence
*	BiomarkerRel T317 T316
T318	BiomarkerName 2137 2139	PR
A105	HistoryVal T318 new
A106	EpisodeDescription T318 FirstOccurrence
T319	BiomarkerResult 2139 2145	+ >95%
A107	HistoryVal T319 new
A108	EpisodeDescription T319 FirstOccurrence
*	BiomarkerRel T319 T318
T320	BiomarkerName 2147 2151	HER2
A109	HistoryVal T320 new
A110	EpisodeDescription T320 FirstOccurrence
T322	LocalInvasion 2189 2192	LVI
A113	NegationModalityVal T322 uncertain_in_past
A114	HistoryVal T322 new
A115	EpisodeDescription T322 FirstOccurrence
R59	TestOrProcedureReveals Test:T308 Desc:T315	
R60	TestOrProcedureReveals Test:T308 Desc:T316	
R61	TestOrProcedureReveals Test:T308 Desc:T318	
R62	TestOrProcedureReveals Test:T308 Desc:T320	
R63	TestOrProcedureReveals Test:T308 Desc:T322	
T323	MarginStatus 2202 2210	negative
A116	MarginVal T323 MoreThan2mm(Neg)
A117	IsTumorRemaining T308 no
T324	Histology 2212 2246	focal high grade DCIS within tumor
A118	HistoryVal T324 new
A119	EpisodeDescription T324 FirstOccurrence
R64	TestOrProcedureReveals Test:T308 Desc:T324	
T325	LymphNodeInvolvement 2248 2251	0/8
A120	NegationModalityVal T325 negated
A121	HistoryVal T325 new
A122	EpisodeDescription T325 FirstOccurrence
R65	TestOrProcedureReveals Test:T311 Desc:T325	
T326	ProcedureName 2350 2368	partial mastectomy
A126	IntentVal T326 treatment-curative
A127	TreatmentTypeVal T326 local
A128	IsTumorRemaining T326 no
T327	Site 2343 2349	breast
R67	SiteOf Arg1:T327 Arg2:T326	
T329	ProcedureName 2382 2403	lymph node dissection
A129	IntentVal T329 DiagnosisAndTreatment
A130	TreatmentTypeVal T329 local
A131	IsTumorRemaining T329 no
T330	Site 2373 2381	axillary
T331	Laterality 2337 2342	Right
R68	LateralityOfSite Arg1:T331 Arg2:T330	
R69	SiteOf Arg1:T330 Arg2:T329	
T332	Size 2405 2411	2.0 cm
A132	HistoryVal T332 new
A133	EpisodeDescription T332 FirstOccurrence
T333	Grade 2418 2419	1
A134	HistoryVal T333 new
A135	EpisodeDescription T333 FirstOccurrence
T334	Histology 2420 2423	IDC
A136	HistoryVal T334 new
A137	EpisodeDescription T334 FirstOccurrence
T335	BiomarkerName 2429 2431	ER
A138	HistoryVal T335 new
A139	EpisodeDescription T335 FirstOccurrence
T336	BiomarkerResult 2431 2436	+ 99%
A140	HistoryVal T336 new
A141	EpisodeDescription T336 FirstOccurrence
*	BiomarkerRel T335 T336
T337	BiomarkerName 2438 2440	PR
A142	HistoryVal T337 new
A143	EpisodeDescription T337 FirstOccurrence
T338	BiomarkerResult 2440 2445	+ 90%
A144	HistoryVal T338 new
*	BiomarkerRel T337 T338
A145	HistoryVal T76 new
A146	EpisodeDescription T76 FirstOccurrence
T339	BiomarkerResult 2451 2452	-
A147	NegationModalityVal T339 negated
A149	EpisodeDescription T339 FirstOccurrence
*	BiomarkerRel T76 T339
T340	LymphNodeInvolvement 2478 2484	0/8 LN
A150	NegationModalityVal T340 negated
A151	HistoryVal T340 new
A152	EpisodeDescription T340 FirstOccurrence
T341	Symptom 2689 2708	mld joint stiffness
A153	IsPresentOnFirstCancerDiagnosis T341 yes
A154	IsCausedByDiagnosedCancer T341 no
A155	ChronicVal T341 chronic
A156	ContinuityVal T341 stable
T342	Site 2731 2736	knees
R70	SiteOf Arg1:T342 Arg2:T341	
T343	TreatmentType 2833 2845	chemotherapy
A157	NegationModalityVal T343 hypothetical_in_future
A158	TreatmentTypeVal T343 adjuvant
T344	MedicationRegimen 2898 2900	TC
A159	NegationModalityVal T344 hypothetical_in_future
A160	TreatmentTypeVal T344 adjuvant
A161	TreatmentIntentVal T344 curative
*	TreatmentTypeRel T344 T343
T345	GenomicTest 3006 3014	Oncotype
A162	NegationModalityVal T345 hypothetical_in_future
A163	IntentVal T345 diagnosis
T346	TreatmentType 3092 3104	chemotherapy
A164	TreatmentTypeVal T346 adjuvant
T86	ClinicalCondition 4043 4051	menarche
A165	NegationModalityVal T86 affirmed
A166	ContinuityVal T86 stopped
A167	ExperiencerVal T86 patient
T347	Age 4055 4063	12 years
T348	ClinicalCondition 4140 4149	menopause
A168	ContinuityVal T348 stopped
A169	ExperiencerVal T348 patient
T349	Age 4153 4161	51 years
T350	TreatmentType 4174 4177	HRT
A170	NegationModalityVal T350 negated
A171	TreatmentTypeVal T350 adjuvant
T351	Employment 4193 4220	worked at ***** Free Clinic
T352	PhysicalActivity 4245 4266	walks 4-5 miles a day
T353	Datetime 4326 4336	10/21/2017
T354	Datetime 4403 4413	10/21/2017
T356	Laterality 5687 5696	bilateral
T358	GenomicTestResult 5790 5819	genomically high risk disease
T359	Site 5832 5838	breast
T360	Laterality 5827 5831	left
R71	LateralityOfSite Arg1:T360 Arg2:T359	
R72	SiteOf Arg1:T359 Arg2:T358	
T361	Stage 5930 5935	early
T362	BiomarkerName 5942 5944	HR
A178	HistoryVal T362 new
A179	EpisodeDescription T362 FirstOccurrence
T363	BiomarkerResult 5944 5945	+
A180	HistoryVal T363 new
A181	EpisodeDescription T363 FirstOccurrence
*	BiomarkerRel T363 T362
T364	BiomarkerName 5946 5950	HER2
A182	HistoryVal T364 new
A183	EpisodeDescription T364 FirstOccurrence
T365	BiomarkerResult 5950 5951	-
A184	NegationModalityVal T365 negated
A185	HistoryVal T365 new
A186	EpisodeDescription T365 FirstOccurrence
*	BiomarkerRel T364 T365
T366	ClinicalCondition 5959 5965	cancer
A187	ChronicVal T366 non-chronic
A188	ContinuityVal T366 new
T367	Radiology 5994 6001	imaging
T368	Pathology 6006 6023	pathology reports
T369	Stage 6125 6128	III
T370	BiomarkerName 6136 6138	HR
T371	BiomarkerResult 6138 6139	+
A189	NegationModalityVal T371 affirmed
*	BiomarkerRel T370 T371
T372	BiomarkerResult 6144 6145	-
A190	NegationModalityVal T372 negated
T373	BiomarkerName 6140 6144	HER2
*	BiomarkerRel T373 T372
T374	Grade 6152 6153	3
T375	Histology 6154 6157	IDC
T376	Site 6170 6176	breast
T377	Laterality 6165 6169	left
R73	LateralityOfSite Arg1:T377 Arg2:T376	
R74	SiteOf Arg1:T376 Arg2:T375	
R75	SiteOf Arg1:T376 Arg2:T374	
T378	Stage 6211 6212	I
T379	BiomarkerName 6221 6223	HR
T380	BiomarkerResult 6223 6224	+
*	BiomarkerRel T380 T379
T381	BiomarkerName 6225 6229	HER2
T382	BiomarkerResult 6229 6230	-
A191	NegationModalityVal T382 negated
*	BiomarkerRel T382 T381
T383	Grade 6237 6238	1
T384	Histology 6239 6242	IDC
T385	Site 6256 6262	breast
T386	Laterality 6250 6255	right
R76	LateralityOfSite Arg1:T386 Arg2:T385	
R77	SiteOf Arg1:T385 Arg2:T384	
R78	SiteOf Arg1:T385 Arg2:T383	
R79	SiteOf Arg1:T385 Arg2:T381	
R80	SiteOf Arg1:T385 Arg2:T379	
T387	TreatmentType 6516 6528	chemotherapy
A192	NegationModalityVal T387 hypothetical_in_future
A193	TreatmentTypeVal T387 adjuvant
T388	GenomicTest 6611 6621	MammaPrint
A194	NegationModalityVal T388 hypothetical_in_future
T389	GenomicTest 6626 6634	Oncotype
A195	NegationModalityVal T389 hypothetical_in_future
T390	ClinicalTrial 6714 6721	MINDACT
T391	GenomicTestResult 6783 6800	high genomic risk
T392	TreatmentType 6818 6830	chemotherapy
A197	TreatmentTypeVal T392 adjuvant
A198	TreatmentTypeVal T165 adjuvant
T393	GenomicTest 7172 7186	Oncotype DX RS
A199	NegationModalityVal T393 affirmed
A200	IntentVal T393 staging
T394	GenomicTest 7328 7338	Oncotype I
A201	NegationModalityVal T394 hypothetical_in_future
A202	IntentVal T394 staging
T395	TreatmentType 7361 7373	chemotherapy
A203	TreatmentTypeVal T395 adjuvant
T396	ClinicalTrial 7527 7534	TAILORx
T397	LymphNodeInvolvement 7567 7578	positive LN
A204	NegationModalityVal T397 affirmed
*	ExclusionCriteriaFor T397 T396
T398	TreatmentType 7640 7661	chemotherapy regimens
A205	TreatmentTypeVal T398 adjuvant
T399	MedicationRegimen 7681 7683	TC
A206	NegationModalityVal T399 hypothetical_in_future
A208	TreatmentTypeVal T399 adjuvant
A209	TreatmentIntentVal T399 curative
T400	Cycles 7686 7687	4
*	TreatmentDesc T400 T399
T401	MedicationRegimen 7700 7704	AC/T
A210	NegationModalityVal T401 hypothetical_in_future
A211	TreatmentTypeVal T401 adjuvant
A212	TreatmentIntentVal T401 curative
T402	ClinicalTrial 7727 7730	ABC
T403	LymphNodeInvolvement 7769 7782	1 positive LN
A213	NegationModalityVal T403 affirmed
T404	MedicationRegimen 7843 7858	TC chemotherapy
A214	NegationModalityVal T404 hypothetical_in_future
A215	TreatmentTypeVal T404 adjuvant
A216	TreatmentIntentVal T404 curative
A217	NegationModalityVal T182 hypothetical_in_future
A218	NegationModalityVal T183 hypothetical_in_future
A219	IsPresentOnFirstCancerDiagnosis T183 no
A220	IsCausedByDiagnosedCancer T183 no
A221	ChronicVal T183 non-chronic
R81	ConditionOrTreatmentCausesProblem Treatment:T404 Prob:T182	
R82	ConditionOrTreatmentCausesProblem Treatment:T404 Prob:T183	
T405	Symptom 7897 7907	joint pain
A222	NegationModalityVal T405 hypothetical_in_future
T406	Symptom 7909 7917	myalgias
A223	NegationModalityVal T406 hypothetical_in_future
T407	Symptom 7919 7934	fluid retention
A224	NegationModalityVal T407 hypothetical_in_future
T408	Symptom 7936 7955	finger nail changes
A225	NegationModalityVal T408 hypothetical_in_future
T409	Symptom 7957 7965	alopecia
A226	NegationModalityVal T409 hypothetical_in_future
T410	Symptom 7971 7992	cognitive dysfunction
A227	NegationModalityVal T410 hypothetical_in_future
R83	ConditionOrTreatmentCausesProblem Treatment:T404 Prob:T405	
R84	ConditionOrTreatmentCausesProblem Treatment:T404 Prob:T406	
R85	ConditionOrTreatmentCausesProblem Treatment:T404 Prob:T407	
R86	ConditionOrTreatmentCausesProblem Treatment:T404 Prob:T408	
R87	ConditionOrTreatmentCausesProblem Treatment:T404 Prob:T409	
R88	ConditionOrTreatmentCausesProblem Treatment:T404 Prob:T410	
T412	Site 8023 8029	breast
T413	Laterality 8017 8022	right
R89	LateralityOfSite Arg1:T413 Arg2:T412	
T414	LymphNodeInvolvement 8106 8108	LN
A228	NegationModalityVal T414 negated
R91	SiteOf Arg1:T412 Arg2:T414	
T415	BiomarkerName 8279 8281	HR
T416	BiomarkerResult 8281 8282	+
*	BiomarkerRel T415 T416
T417	BiomarkerName 8283 8287	HER2
T418	BiomarkerResult 8287 8288	-
A229	NegationModalityVal T418 negated
*	BiomarkerRel T417 T418
T419	TreatmentType 8344 8357	anti-estrogen
A230	NegationModalityVal T419 hypothetical_in_future
A231	TreatmentTypeVal T419 adjuvant
A232	TreatmentIntentVal T419 curative
T420	TreatmentType 8498 8511	anti-estrogen
A233	NegationModalityVal T420 hypothetical_in_future
A234	TreatmentTypeVal T420 adjuvant
A235	TreatmentIntentVal T420 curative
T421	BiomarkerName 8554 8556	HR
T422	BiomarkerResult 8556 8557	+
*	BiomarkerRel T421 T422
T423	BiomarkerName 8558 8562	HER2
T424	BiomarkerResult 8562 8563	-
A236	NegationModalityVal T424 negated
*	BiomarkerRel T423 T424
T425	TreatmentType 8584 8608	aromatase inhibitor (AI)
A237	NegationModalityVal T425 hypothetical_in_future
A238	TreatmentTypeVal T425 adjuvant
A239	TreatmentIntentVal T425 curative
R92	TreatmentAdministeredForProblem Treatment:T425 Prob:T421	
T426	Symptom 8752 8763	hot flashes
A240	NegationModalityVal T426 hypothetical_in_future
T427	Symptom 8765 8776	arthralgias
A241	NegationModalityVal T427 hypothetical_in_future
T428	Symptom 8778 8793	vaginal dryness
A242	NegationModalityVal T428 hypothetical_in_future
T429	Symptom 8799 8816	bone density loss
A243	NegationModalityVal T429 hypothetical_in_future
R93	ConditionOrTreatmentCausesProblem Treatment:T425 Prob:T426	
R94	ConditionOrTreatmentCausesProblem Treatment:T425 Prob:T427	
R95	ConditionOrTreatmentCausesProblem Treatment:T425 Prob:T428	
R96	ConditionOrTreatmentCausesProblem Treatment:T425 Prob:T429	
T430	MedicationName 8847 8849	AI
A244	NegationModalityVal T430 hypothetical_in_future
A245	TreatmentTypeVal T430 adjuvant
A246	TreatmentIntentVal T430 curative
T431	Duration 8854 8870	at least 5 years
T432	TreatmentType 8931 8940	radiation
A247	NegationModalityVal T432 hypothetical_in_future
A248	TreatmentTypeVal T432 local
T433	MedicationRegimen 9307 9333	docetaxel/cyclophosphamide
A249	NegationModalityVal T433 hypothetical_in_future
A250	TreatmentTypeVal T433 adjuvant
A251	TreatmentIntentVal T433 curative
T434	Cycles 9336 9337	4
*	TreatmentDesc T433 T434
T435	TreatmentType 9348 9357	radiation
A252	TreatmentTypeVal T435 local
T436	TreatmentType 9361 9363	AI
A253	NegationModalityVal T436 hypothetical_in_future
A254	TreatmentTypeVal T436 adjuvant
A255	TreatmentIntentVal T436 curative
T437	Duration 9376 9392	at least 5 years
T438	MedicationName 9425 9440	CDK4/6 inhibito
A256	NegationModalityVal T438 hypothetical_in_future
A257	TreatmentTypeVal T438 adjuvant
A258	TreatmentIntentVal T438 curative
R97	SiteOf Arg1:T297 Arg2:T301	
T357	TreatmentType 5744 5756	chemotherapy
A176	TreatmentTypeVal T357 adjuvant
R98	TreatmentAdministeredForProblem Treatment:T420 Prob:T421	
R57	TestOrProcedureReveals Test:T308 Desc:T313	
*	ProcedureDesc T308 T323
T68	ClinicalCondition 81 87	cancer
A8	HistoryVal T68 new
A14	EpisodeDescription T68 FirstOccurrence
T440	Stage 62 67	early
T441	ClinicalCondition 8030 8036	cancer
T442	MedicationName 9109 9116	calcium
A20	TreatmentCategory T442 Supportive
T443	MedicationName 9121 9130	vitamin D
A22	TreatmentCategory T443 Supportive
T444	PhysicalActivity 9168 9184	aerobic activity
T445	PhysicalActivity 9258 9271	daily walking
R58	HappensAtOnDuring Arg1:T230 Arg2:T231	
R99	HappensAtOnDuring Arg1:T233 Arg2:T232	
R100	HappensAtOnDuring Arg1:T226 Arg2:T229	
R101	HappensAtOnDuring Arg1:T237 Arg2:T236	
R102	HappensAtOnDuring Arg1:T256 Arg2:T255	
R103	HappensAtOnDuring Arg1:T269 Arg2:T255	
R104	HappensAtOnDuring Arg1:T284 Arg2:T283	
R105	HappensAtOnDuring Arg1:T296 Arg2:T295	
R106	HappensAtOnDuring Arg1:T308 Arg2:T307	
R107	HappensAtOnDuring Arg1:T311 Arg2:T307	
R108	HappensAtOnDuring Arg1:T326 Arg2:T307	
R109	HappensAtOnDuring Arg1:T329 Arg2:T307	
A123	SectionSkipType T3 physical_exam
R110	BeginsOnOrAt Arg1:T348 Arg2:T349	
R111	BeginsOnOrAt Arg1:T86 Arg2:T347	
T446	MaritalStatus 3660 3667	Married
T447	Tobacco 3838 3850	Never Smoker
A207	NegationModalityVal T447 negated
T448	Tobacco 3855 3884	Smokeless tobacco: Never Used
A264	NegationModalityVal T448 negated
T449	Alcohol 3889 3903	Alcohol use No
A265	NegationModalityVal T449 negated
T450	Drugs 3908 3912;3915 3922	Drug use: No
A266	NegationModalityVal T450 negated
T451	SDoH 3927 3947	Sexual activity: Yes
A269	BiomarkerResultVal T317 Positive
A270	BiomarkerResultVal T319 Positive
A272	BiomarkerResultVal T279 Positive
A273	BiomarkerResultVal T277 Positive
A274	BiomarkerResultVal T264 Positive
A275	BiomarkerResultVal T266 Positive
A276	BiomarkerResultVal T336 Positive
A277	BiomarkerResultVal T338 Positive
A278	BiomarkerResultVal T339 Negative
A148	BiomarkerResultVal T365 Negative
A279	BiomarkerResultVal T363 Positive
A280	BiomarkerResultVal T382 Negative
A281	BiomarkerResultVal T380 Positive
A282	BiomarkerResultVal T371 Positive
A283	BiomarkerResultVal T372 Negative
A284	BiomarkerResultVal T416 Positive
A285	BiomarkerResultVal T418 Negative
A286	BiomarkerResultVal T424 Negative
A287	BiomarkerResultVal T422 Positive
T452	PhysicalActivity 9065 9088	weight bearing exercise
A288	NegationModalityVal T452 hypothetical_in_future
T453	Site 698 704	breast
R112	LateralityOfSite Arg1:T244 Arg2:T453	
T454	Pathology 1070 1073	IHC
A289	IntentVal T454 diagnosis
T455	Pathology 1218 1221	IHC
A290	IntentVal T455 diagnosis
T456	Pathology 1078 1088	FISH ratio
A291	IntentVal T456 diagnosis
T457	RadPathResult 1074 1076	1+
R113	ResultOfTest Desc:T457 Test:T454	
T458	RadPathResult 1089 1092	1.1
A292	RadPathResultVal T458 Others
R114	ResultOfTest Desc:T458 Test:T456	
T281	BiomarkerResult 1215 1216	+
A58	HistoryVal T281 new
A59	EpisodeDescription T281 FirstOccurrence
A271	BiomarkerResultVal T281 Positive
R115	BiomarkerRel Arg1:T281 Arg2:T280	
T459	Pathology 1226 1230	FISH
A293	IntentVal T459 diagnosis
T460	RadPathResult 1222 1224	2+
A294	RadPathResultVal T460 Others
R116	ResultOfTest Desc:T460 Test:T455	
T461	RadPathResult 1237 1270	2.0 with HER2 copy # per cell 4.4
A295	RadPathResultVal T461 Others
R117	ResultOfTest Desc:T461 Test:T459	
T462	Site 1420 1426	breast
T463	Laterality 1414 1419	right
R118	LateralityOfSite Arg1:T463 Arg2:T462	
R119	LateralityOfSite Arg1:T463 Arg2:T289	
T464	Site 1565 1571	breast
T465	Laterality 1560 1564	left
R120	LateralityOfSite Arg1:T465 Arg2:T464	
R121	SiteOf Arg1:T464 Arg2:T292	
R122	SiteOf Arg1:T464 Arg2:T291	
T466	RadPathResult 1572 1582	index mass
A296	RadPathResultVal T466 InitialCancerDiagnosis
R123	SiteOf Arg1:T464 Arg2:T466	
T467	Site 1658 1666	axillary
T468	Laterality 1653 1657	left
T469	Site 1641 1652	low level 1
R124	LateralityOfSite Arg1:T468 Arg2:T469	
R125	LateralityOfSite Arg1:T468 Arg2:T467	
T470	Laterality 1716 1721	right
T306	BiomarkerResult 2002 2003	-
A87	BiomarkerResultVal T306 Negative
R126	BiomarkerRel Arg1:T306 Arg2:T305	
T471	Pathology 2005 2008	IHC
A88	IntentVal T471 diagnosis
T472	RadPathResult 2009 2011	1+
A89	RadPathResultVal T472 Others
R127	ResultOfTest Desc:T472 Test:T471	
T473	Pathology 2013 2017	FISH
A267	IntentVal T473 diagnosis
T474	RadPathResult 2024 2027	1.2
A297	RadPathResultVal T474 Others
R128	ResultOfTest Desc:T474 Test:T473	
T475	GenomicTest 2314 2316	MP
A298	IntentVal T475 staging
A299	GenomicTestType T475 GeneExpression
T476	GenomicTestResult 2328 2334	-0.614
A300	GenomicTestType T476 GeneExpression
R129	ResultOfTest Desc:T476 Test:T475	
T477	GenomicTest 2487 2489	MP
A301	IntentVal T477 staging
A302	GenomicTestType T477 GeneExpression
T478	GenomicTestResult 2500 2506	+0.321
A303	GenomicTestType T478 GeneExpression
R130	ResultOfTest Desc:T478 Test:T477	
T479	Site 2659 2665	breast
T480	ProcedureName 2666 2673	surgery
A304	IntentVal T480 DiagnosisAndTreatment
R131	SiteOf Arg1:T479 Arg2:T480	
T321	BiomarkerResult 2151 2152	-
A111	EpisodeDescription T321 FirstOccurrence
A112	BiomarkerResultVal T321 Negative
R132	BiomarkerRel Arg1:T321 Arg2:T320	
T481	RadPathResult 2154 2156	1+
T482	Pathology 2158 2162	FISH
A268	IntentVal T482 diagnosis
T483	RadPathResult 2169 2172	1.0
R133	ResultOfTest Desc:T483 Test:T482	
T484	ClinicalCondition 3192 3205	Breast cancer
A305	ChronicVal T484 non-chronic
A306	ContinuityVal T484 stable
A307	ExperiencerVal T484 patient
T485	ClinicalCondition 3211 3219	Diabetes
A308	ChronicVal T485 chronic
A309	ContinuityVal T485 stable
T486	Datetime 3220 3230	08/09/2017
T487	Datetime 3243 3253	October 20
T488	Datetime 3257 3265	08/09/17
T489	ClinicalCondition 3271 3278	Obesity
A310	ChronicVal T489 chronic
A311	ContinuityVal T489 stable
T490	Datetime 3382 3392	10/09/2017
T491	Laterality 3372 3381	Bilateral
T492	ProcedureName 3341 3371	AXILLARY LYMPH NODE DISSECTION
A312	IntentVal T492 DiagnosisAndTreatment
A313	IsTumorRemaining T492 no
T493	ProcedureName 3429 3448	MASTECTOMY, PARTIAL
A314	IntentVal T493 DiagnosisAndTreatment
T494	Laterality 3449 3458	Bilateral
T495	Datetime 3459 3469	08/13/2017
R134	HappensAtOnDuring Arg1:T490 Arg2:T492	
R135	HappensAtOnDuring Arg1:T495 Arg2:T493	
T496	ClinicalCondition 3561 3574	Breast cancer
A315	ExperiencerVal T496 family
T497	MedicationName 4082 4085	OCP
A316	NegationModalityVal T497 affirmed
A317	TreatmentContinuityVal T497 finished
A318	TreatmentIntentVal T497 others
A319	TreatmentCategory T497 Others
T498	Duration 4092 4098	1 year
R136	HappensOverlapping Arg1:T498 Arg2:T497	
T355	ClinicalCondition 5704 5710	cancer
A172	ChronicVal T355 non-chronic
A173	ContinuityVal T355 stable
A174	TreatmentContinuityVal T357 planned
A175	TreatmentIntentVal T357 curative
T499	GenomicTest 6178 6180	MP
A259	IntentVal T499 staging
A260	GenomicTestType T499 GeneExpression
T500	GenomicTestResult 6191 6197	-0.614
A321	GenomicTestType T500 GeneExpression
R137	ResultOfTest Desc:T500 Test:T499	
T501	GenomicTest 6264 6266	MP
A322	IntentVal T501 staging
A323	GenomicTestType T501 GeneExpression
T502	GenomicTestResult 6267 6275	low risk
A324	GenomicTestType T502 GeneExpression
R138	ResultOfTest Desc:T502 Test:T501	
T503	ClinicalCondition 6313 6319	cancer
A325	ChronicVal T503 non-chronic
A326	ContinuityVal T503 stable
T504	Laterality 6301 6305	left
T506	LymphNodeInvolvement 6384 6401	lymph node status
A327	NegationModalityVal T506 affirmed
A329	TreatmentTypeVal T164 adjuvant
A330	NegationModalityVal T165 hypothetical_in_future
T507	GenomicTestResult 7305 7322	high risk disease
A331	GenomicTestType T507 GeneExpression
R139	ResultOfTest Desc:T507 Test:T394	
A332	NegationModalityVal T395 hypothetical_in_future
T508	TumorCharacteristics 7590 7605	micrometastasis
A333	EpisodeDescription T508 FirstOccurrence
A335	NegationModalityVal T193 hypothetical_in_future
A336	TreatmentTypeVal T193 adjuvant
A337	TreatmentIntentVal T193 curative
A338	NegationModalityVal T212 hypothetical_in_future
A339	TreatmentTypeVal T212 adjuvant
A340	TreatmentIntentVal T212 curative
T510	ProcedureName 8971 8975	DEXA
A341	NegationModalityVal T510 planned_in_future
A342	IntentVal T510 screening
A343	NegationModalityVal T444 affirmed
T511	Frequency 9186 9204	150 minutes a week
R142	Temporal Arg1:T511 Arg2:T444	
R143	Temporal Arg1:T511 Arg2:T445	
R144	TumorDesc TumorDetails:T440 Desc:T68	
T512	Age 21 23	55
T513	Datetime 190 198	10/21/17
T514	Age 5629 5635	55 y.o
R145	TumorDesc TumorDetails:T361 Desc:T366	
R146	TumorDesc TumorDetails:T362 Desc:T366	
R147	TumorDesc TumorDetails:T362 Desc:T366	
R148	TumorDesc TumorDetails:T364 Desc:T366	
R149	TestOrProcedureReveals Test:T256 Desc:T262	
R150	TestOrProcedureReveals Test:T269 Desc:T274	
R151	TestOrProcedureReveals Test:T269 Desc:T275	
R152	TestOrProcedureReveals Test:T256 Desc:T263	
R153	TestOrProcedureReveals Test:T256 Desc:T265	
R154	TestOrProcedureReveals Test:T256 Desc:T267	
R155	HappensOverlapping Arg1:T436 Arg2:T437	
R156	HappensOverlapping Arg1:T430 Arg2:T431	
A347	NegationModalityVal T346 hypothetical_in_future
A348	NegationModalityVal T398 hypothetical_in_future
T515	TreatmentType 8584 8603	aromatase inhibitor
A349	NegationModalityVal T515 hypothetical_in_future
A350	TreatmentTypeVal T515 adjuvant
A351	TreatmentIntentVal T515 curative
A352	NegationModalityVal T442 planned_in_future
A353	NegationModalityVal T443 planned_in_future
T516	GenomicTestResult 2317 2326	high risk
R157	ResultOfTest Desc:T516 Test:T475	
A354	GenomicTestType T516 GeneExpression
T517	GenomicTestResult 2490 2498	Low Risk
A355	GenomicTestType T517 GeneExpression
R158	ResultOfTest Desc:T517 Test:T477	
T518	GenomicTestResult 6181 6190	high risk
A356	GenomicTestType T518 GeneExpression
R159	ResultOfTest Desc:T518 Test:T499	
A357	ExperiencerVal T402 others
R160	InclusionCriteriaFor Arg1:T403 Arg2:T399	
R161	ExclusionCriteriaFor Arg1:T403 Arg2:T401	
A358	ExperiencerVal T390 others
A196	ExperiencerVal T392 others
A328	ExperiencerVal T164 others
T519	DiseaseState 7024 7042	distant recurrence
A359	NegationModalityVal T519 hypothetical_in_future
A360	NegationModalityVal T396 negated
T509	Site 74 80	breast
R141	SiteOf Arg1:T509 Arg2:T68	
R162	TestOrProcedureReveals Test:T454 Desc:T267	
R163	TestOrProcedureReveals Test:T456 Desc:T267	
R164	TestOrProcedureReveals Test:T455 Desc:T280	
R165	TestOrProcedureReveals Test:T459 Desc:T280	
R34	ResultOfTest Desc:T287 Test:T284	
R36	LateralityOfSite Arg1:T290 Arg2:T464	
R166	LateralityOfSite Arg1:T290 Arg2:T293	
R167	TestOrProcedureReveals Test:T471 Desc:T305	
R168	TestOrProcedureReveals Test:T473 Desc:T305	
R169	LateralityOfSite Arg1:T298 Arg2:T299	
R170	ResultOfTest Desc:T481 Test:T482	
R171	TestOrProcedureReveals Test:T482 Desc:T320	
A334	NegationModalityVal T70 negated
R172	TestOrProcedureReveals Test:T311 Desc:T69	
R173	TestOrProcedureReveals Test:T311 Desc:T70	
R66	LateralityOfSite Arg1:T331 Arg2:T327	
R174	TestOrProcedureReveals Test:T326 Desc:T332	
R175	TestOrProcedureReveals Test:T326 Desc:T333	
R176	TestOrProcedureReveals Test:T326 Desc:T334	
R177	TestOrProcedureReveals Test:T326 Desc:T335	
R178	TestOrProcedureReveals Test:T326 Desc:T337	
R179	TestOrProcedureReveals Test:T326 Desc:T76	
T328	Pathology 2454 2457	IHC
A361	IntentVal T328 diagnosis
R180	TestOrProcedureReveals Test:T328 Desc:T76	
T520	Pathology 2461 2465	FISH
A362	IntentVal T520 diagnosis
R181	TestOrProcedureReveals Test:T520 Desc:T76	
T521	RadPathResult 2458 2459	0
T522	RadPathResult 2472 2475	1.5
R182	ResultOfTest Desc:T521 Test:T328	
R183	ResultOfTest Desc:T522 Test:T520	
T523	PatientCharacteristics 4108 4112	G0P0
T524	Site 5697 5703	breast
R184	SiteOf Arg1:T524 Arg2:T355	
R185	LateralityOfSite Arg1:T356 Arg2:T524	
R186	InclusionCriteriaFor Arg1:T358 Arg2:T357	
T439	Site 5952 5958	breast
R187	SiteOf Arg1:T439 Arg2:T366	
R188	TumorDesc TumorDetails:T362 Desc:T366	
R189	SiteOf Arg1:T376 Arg2:T370	
R190	SiteOf Arg1:T376 Arg2:T373	
R191	SiteOf Arg1:T376 Arg2:T369	
R192	SiteOf Arg1:T376 Arg2:T499	
R193	SiteOf Arg1:T385 Arg2:T378	
R194	SiteOf Arg1:T385 Arg2:T501	
T525	Site 6306 6312	breast
R195	SiteOf Arg1:T525 Arg2:T503	
R196	LateralityOfSite Arg1:T504 Arg2:T525	
R197	SiteOf Arg1:T412 Arg2:T441	
R198	TreatmentAdministeredForProblem Treatment:T419 Prob:T415	
R90	InclusionCriteriaFor Arg1:T507 Arg2:T395	
T411	TNM 6214 6219	T1cN0
R140	SiteOf Arg1:T385 Arg2:T411	
T505	TNM 6130 6134	T3N1
R199	SiteOf Arg1:T376 Arg2:T505	
A261	DiseaseStateVal T519 progression-recurrence
R200	SizeOf Arg1:T260 Arg2:T262	
R201	SizeOf Arg1:T273 Arg2:T275	
R202	SizeOf Arg1:T288 Arg2:T287	
R203	SizeOf Arg1:T292 Arg2:T291	
R204	SizeOf Arg1:T302 Arg2:T300	
R205	SizeOf Arg1:T314 Arg2:T315	
R206	SizeOf Arg1:T332 Arg2:T334	
T526	hpi_start 0 2	ID
T527	ap_start 5596 5606	Assessment
T528	ap_end 9683 9691	options.
T529	hpi_end 3137 3143	risks.
